KVUE · Kenvue Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Essential Health Segment adjusted operating income non-GAAP | $315M | fiscal three months ended June 28, 2026 filing | — |
| Segment adjusted operating income non-GAAP | $1.01B | the fiscal three months ended June 28, 2026 filing | — |
| Self Care Segment adjusted operating income non-GAAP | $512M | fiscal three months ended June 28, 2026 filing | — |
| Skin Health and Beauty Segment adjusted operating income non-GAAP | $186M | fiscal three months ended June 28, 2026 filing | — |
| Total Segment adjusted operating income non-GAAP | $1.01B | fiscal three months ended June 28, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KVUE
this stock
Kenvue Inc.
|
$34.19B | +0.8% | -2.1% | — | 3.0% |
|
PG
PROCTER & GAMBLE Co
|
$339.90B | +1.8% | +3.3% | 22.1 | 1.0% |
|
UL
Unilever PLC
|
$134.67B | -8.3% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$69.13B | +9.1% | +1.7% | 34.3 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$41.79B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KVUE | -2.7% | -7.2% | +0.1% | -1.5% | +0.8% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -3.9% | -7.8% | -11.5% | -3.1% | -12.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.